Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GRTX | Galera Therapeutics, Inc. | Chief Financial Officer | $10.7K | Mar 13, 2023 | ||
URGN | UroGen Pharma Ltd. | Chief Financial Officer | Oct 8, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|